DoW Tick-Borne Disease Therapeutic/Diagnostic Research Award
Agency: Defense Health Agency Contracting Activity - DHACA
Assistance Listings: 12.420 -- Military Medical Research and Development
Description
Summary: The intent of the fiscal year 2026 (FY26) Tick-Borne Disease Research Program (TBDRP) Therapeutic/Diagnostic Research Award (TDRA) is to support product-driven therapeutic and diagnostic development research aimed at reducing the burden of Lyme disease and/or other tick-borne diseases and conditions, and improving patient care and/or quality of life. Treatment-focused applications should be therapeutic evaluation studies designed to advance new ideas aimed at drug or treatment discovery that are still in the early/preclinical stages of development. Diagnosis-focused applications should propose diagnostic approaches that will be readily integrated into clinical settings.
https://cdmrp.health.mil/pubs/press/2026/tbdrppreann
Eligibility
Eligible applicants
Miscellaneous
- Unrestricted
Additional information
Grantor contact information
Description
eBRAP Help Desk
Documents
| File name | Description | Last updated |
|---|---|---|
| HT942526TBDRPTDRA_GG.pdf | FY26 TBDRP TDRA Program Announcement | May 6, 2026 03:14 PM UTC |
Link to additional information
--
Closing: October 22, 2026
Award
$2,650,000
Program Funding
2
Expected awards
$--
Award Minimum
$--
Award Maximum
Funding opportunity number:
HT942526TBDRPTDRA
Cost sharing or matching requirement:
Funding instrument type:
Grant
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Science technology and other research and development
Category Explanation:
History
Version:
4
Posted date:
May 5, 2026
Archive date:
November 21, 2026
